1998
DOI: 10.1006/bcmd.1998.0189
|View full text |Cite
|
Sign up to set email alerts
|

Oncoprotein v-Myb and Retinoic Acid Receptor α Are Mutual Antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
11
0

Year Published

1999
1999
2007
2007

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 33 publications
1
11
0
Order By: Relevance
“…The hypothesis that c-Fos functions as a transcriptional repressor in order to activate programmed cell death is further supported by the fact that the protein synthesis inhibitor CHX did not block c-Fos-induced apoptosis of BM2cFOS cells. v-Myb shares proliferation-promoting and apoptosissuppressing activities with c-Myb but it does not permit the activation of genes required for terminal differentiation of its cellular progenitor [57,70,71]. This study and our previous paper [27] document that transcription factors Fos and Jun that form the AP-1 complex can significantly affect the function of the v-Myb oncoprotein.…”
Section: Discussionmentioning
confidence: 55%
“…The hypothesis that c-Fos functions as a transcriptional repressor in order to activate programmed cell death is further supported by the fact that the protein synthesis inhibitor CHX did not block c-Fos-induced apoptosis of BM2cFOS cells. v-Myb shares proliferation-promoting and apoptosissuppressing activities with c-Myb but it does not permit the activation of genes required for terminal differentiation of its cellular progenitor [57,70,71]. This study and our previous paper [27] document that transcription factors Fos and Jun that form the AP-1 complex can significantly affect the function of the v-Myb oncoprotein.…”
Section: Discussionmentioning
confidence: 55%
“…We and others recently described that the v-Myb and RAR proteins reciprocally modify each others' functions, thus they can be considered as mutual antagonists [41][42][43]69]. RAR␣ expressed in v-myb-transformed monoblasts suppressed transformation and permitted RA-dependent differentiation into macrophage-like cells [41].…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, the v-myb-transformed monoblasts expressing either RAR␣ or RXR␣ differentiate without apoptosis on activation by RA. The number of apoptotic cells detected in a population of RA-treated BM2RAR␣ and BM2RXR␣ cells was very low, suggesting that there is an efficient block of apoptotic processes in BM2 cells, presumably resulting from anti-apoptotic activities of v-Myb oncoprotein [42,58,59]. In contrast, treatment of BM2 cells with TPA induces both differentiation and apoptosis [50].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, BM2 cells treated with TPA or expressing p53 share other features: they exit cell cycle in the G2-phase and differentiate to mostly mononuclear derivatives (Sˇmarda and Lipsick, 1994;Nemajerova et al, 2003). In contrast, the G1-phase blockers and differentiation inducers, such as trichostatin A or retinoic acid suppress transactivation by the v-Myb oncoprotein and increase formation of multinuclear macrophage-like cells (Sˇmarda et al, 1995;Zemanova and Sˇmarda, 1998;Vodicka et al, 2000;Nemajerova et al, 2003;Sˇmardova´et al, 2005). The G1-phase cell cycle arrest and formation of multinucleated giant cells also occur in chicken yolk sac cells transformed with v-Myb-estrogen receptor fusion protein and withdrawn from estrogen (Engelke et al, 1997).…”
Section: Activity Of the V-myb Oncoprotein Increases In P53-expressinmentioning
confidence: 99%